keyword
https://read.qxmd.com/read/38642863/design-and-construction-of-a-phage-displayed-camelidae-nanobody-library-using-a-simple-bioinformatics-method
#1
JOURNAL ARTICLE
Aliasghar Rahimian, Ali Nabati, Hooman Askari, Mohammad Saffarioun, Mahdi Aminian
BACKGROUND: Rational design of synthetic phage-displayed libraries requires the identification of the most appropriate positions for randomization using defined amino acid sets to recapitulate the natural occurrence. The present study uses position-specific scoring matrixes (PSSMs) for identifying and randomizing Camelidae nanobody (VHH) CDR3. The functionality of a synthetic VHH repertoire designed by this method was tested for discovering new VHH binders to recombinant coagulation factor VII (rfVII)...
April 18, 2024: Protein Expression and Purification
https://read.qxmd.com/read/38642843/tenascin-c-targeting-strategies-in-cancer
#2
REVIEW
Sayda Dhaouadi, Balkiss Bouhaouala-Zahar, Gertraud Orend
Tenascin-C (TNC) is a matricellular and multimodular glycoprotein highly expressed under pathological conditions, especially in cancer and chronic inflammatory diseases. Since a long time TNC is considered as a promising target for diagnostic and therapeutic approaches in anti-cancer treatments and was already extensively targeted in clinical trials on cancer patients. This review provides an overview of the current most advanced strategies used for TNC detection and anti-TNC theranostic approaches including some advanced clinical strategies...
April 18, 2024: Matrix Biology: Journal of the International Society for Matrix Biology
https://read.qxmd.com/read/38637886/the-development-of-chimeric-antigen-receptor-t-cells-against-cd70-for-renal-cell-carcinoma-treatment
#3
JOURNAL ARTICLE
Qinghui Xiong, Haiying Wang, Qiushuang Shen, Yan Wang, Xiujie Yuan, Guangyao Lin, Pengfei Jiang
In this study, we investigated CD70 as a promising target for renal cell carcinoma (RCC) therapy and developed a potent chimeric antigen receptor T (CAR-T) cells for potential clinical testing. CD70, found to be highly expressed in RCC tumors, was associated with decreased survival. We generated CAR-T cells expressing VHH sequence of various novel nanobodies from immunized alpaca and a single-chain variable fragment (scFv) derived from human antibody (41D12). In our in vitro experiments, anti-CD70 CAR-T cells effectively eliminated CD70-positive tumor cells while sparing CD70-negative cells...
April 18, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38632402/brain%C3%A2-endothelial-gsdmd-activation-mediates-inflammatory-bbb-breakdown
#4
JOURNAL ARTICLE
Chao Wei, Wei Jiang, Ruiyu Wang, Haoyu Zhong, Huabin He, Xinwei Gao, Shilin Zhong, Fengting Yu, Qingchun Guo, Li Zhang, Lisa D J Schiffelers, Bin Zhou, Martin Trepel, Florian I Schmidt, Minmin Luo, Feng Shao
The blood-brain barrier (BBB) protects the central nervous system from infections or harmful substances1 ; its impairment can lead to or exacerbate various diseases of the central nervous system2-4 . However, the mechanisms of BBB disruption during infection and inflammatory conditions5,6 remain poorly defined. Here we find that activation of the pore-forming protein GSDMD by the cytosolic lipopolysaccharide (LPS) sensor caspase-11 (refs. 7-9 ), but not by TLR4-induced cytokines, mediates BBB breakdown in response to circulating LPS or during LPS-induced sepsis...
April 17, 2024: Nature
https://read.qxmd.com/read/38626090/correction-biochemical-characterization-of-protease-activity-of-nsp3-from-sars-cov-2-and-its-inhibition-by-nanobodies
#5
Lee A Armstrong, Sven M Lange, Virginia De Cesare, Stephen P Matthews, Raja Sekhar Nirujogi, Isobel Cole, Anthony Hope, Fraser Cunningham, Rachel Toth, Rukmini Mukherjee, Denisa Bojkova, Franz Gruber, David Gray, Paul G Wyatt, Jindrich Cinatl, Ivan Dikic, Paul Davies, Yogesh Kulathu
[This corrects the article DOI: 10.1371/journal.pone.0253364.].
2024: PloS One
https://read.qxmd.com/read/38611711/camel-derived-nanobodies-as-potent-inhibitors-of-new-delhi-metallo-%C3%AE-lactamase-1-enzyme
#6
JOURNAL ARTICLE
Rahma Ben Abderrazek, Emna Hamdi, Alessandra Piccirilli, Sayda Dhaouadi, Serge Muyldermans, Mariagrazia Perilli, Balkiss Bouhaouala-Zahar
The injudicious usage of antibiotics during infections caused by Gram-negative bacteria leads to the emergence of β-lactamases. Among them, the NDM-1 enzyme poses a serious threat to human health. Developing new antibiotics or inhibiting β-lactamases might become essential to reduce and prevent bacterial infections. Nanobodies (Nbs), the smallest antigen-binding single-domain fragments derived from Camelidae heavy-chain-only antibodies, targeting enzymes, are innovative alternatives to develop effective inhibitors...
March 22, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38610029/development-of-nanobodies-targeting-hepatocellular-carcinoma-and-application-of-nanobody-based-car-t-technology
#7
JOURNAL ARTICLE
Keming Lin, Baijin Xia, Xuemei Wang, Xin He, Mo Zhou, Yingtong Lin, Yidan Qiao, Rong Li, Qier Chen, Yuzhuang Li, Jinzhu Feng, Tao Chen, Cancan Chen, Xinyu Li, Hui Zhang, Lijuan Lu, Bingfeng Liu, Xu Zhang
BACKGROUND: Chimeric antigen receptor T (CAR-T) cell therapy, as an emerging anti-tumor treatment, has garnered extensive attention in the study of targeted therapy of multiple tumor-associated antigens in hepatocellular carcinoma (HCC). However, the suppressive microenvironment and individual heterogeneity results in downregulation of these antigens in certain patients' cancer cells. Therefore, optimizing CAR-T cell therapy for HCC is imperative. METHODS: In this study, we administered FGFR4-ferritin (FGFR4-HPF) nanoparticles to the alpaca and constructed a phage library of nanobodies (Nbs) derived from alpaca, following which we screened for Nbs targeting FGFR4...
April 12, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38608697/sonogenetics-controlled-synthetic-designer-cells-for-cancer-therapy-in-tumor-mouse-models
#8
JOURNAL ARTICLE
Tian Gao, Lingxue Niu, Xin Wu, Di Dai, Yang Zhou, Mengyao Liu, Ke Wu, Yuanhuan Yu, Ningzi Guan, Haifeng Ye
Bacteria-based therapies are powerful strategies for cancer therapy, yet their clinical application is limited by a lack of tunable genetic switches to safely regulate the local expression and release of therapeutic cargoes. Rapid advances in remote-control technologies have enabled precise control of biological processes in time and space. We developed therapeutically active engineered bacteria mediated by a sono-activatable integrated gene circuit based on the thermosensitive transcriptional repressor TlpA39 ...
April 5, 2024: Cell reports medicine
https://read.qxmd.com/read/38604764/-68-ga-nc-bch-whole-body-pet-imaging-rapidly-targets-claudin18-2-in-lesions-in-gastrointestinal-cancer-patients
#9
JOURNAL ARTICLE
Changsong Qi, Rui Guo, Yan Chen, Chenzhen Li, Chang Liu, Miao Zhang, Cheng Zhang, Xiaotian Zhang, Xingguo Hou, Bo Chen, Bing Jia, Zhi Yang, Lin Shen, Hua Zhu
68 Ga-labeled nanobody (68 Ga-NC-BCH) is a single-domain antibody-based PET imaging agent. We conducted a first-in-humans study of 68 Ga-NC-BCH for PET to determine its in vivo biodistribution, metabolism, radiation dosimetry, safety, and potential for quantifying claudin-18 isoform 2 (CLDN18.2) expression in gastrointestinal cancer patients. Methods: Initially, we synthesized the probe 68 Ga-NC-BCH and performed preclinical evaluations on human gastric adenocarcinoma cell lines and xenograft mouse models...
April 11, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38603467/proteomics-platform-reveals-broad-spectrum-nanobodies-for-sars-cov-2-variant-neutralization
#10
JOURNAL ARTICLE
Ran Zhang, Lan Huang, Xiaohan Zhang, Yuanling Yu, Te Liang, Hongye Wang, Xiaomei Zhang, Di Hu, Bingwei Wang, Youchun Wang, Junyi Jiang, Xiaobo Yu
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the emergence of different variants of concerns with immune evasion that have been prevalent over the past three years. Nanobodies, the functional variable regions of camelid heavy-chain-only antibodies, have garnered interest in developing neutralizing antibodies due to their smaller size, structural stability, ease of production, high affinity, and low immunogenicity, among other characteristics. In this work, we describe an integrated proteomics platform for the high-throughput screening of nanobodies against different SARS-CoV-2 spike variants...
April 11, 2024: Journal of Proteome Research
https://read.qxmd.com/read/38596311/discovery-and-preclinical-development-of-a-therapeutically-active-nanobody-based-chimeric-antigen-receptor-targeting-human-cd22
#11
JOURNAL ARTICLE
Scott McComb, Mehdi Arbabi-Ghahroudi, Kevin A Hay, Brian A Keller, Sharlene Faulkes, Michael Rutherford, Tina Nguyen, Alex Shepherd, Cunle Wu, Anne Marcil, Annie Aubry, Greg Hussack, Devanand M Pinto, Shannon Ryan, Shalini Raphael, Henk van Faassen, Ahmed Zafer, Qin Zhu, Susanne Maclean, Anindita Chattopadhyay, Komal Gurnani, Rénald Gilbert, Christine Gadoury, Umar Iqbal, Dorothy Fatehi, Anna Jezierski, Jez Huang, Robert A Pon, Mhairi Sigrist, Robert A Holt, Brad H Nelson, Harold Atkins, Natasha Kekre, Eric Yung, John Webb, Julie S Nielsen, Risini D Weeratna
Chimeric antigen receptor (CAR) T cell therapies targeting B cell-restricted antigens CD19, CD20, or CD22 can produce potent clinical responses for some B cell malignancies, but relapse remains common. Camelid single-domain antibodies (sdAbs or nanobodies) are smaller, simpler, and easier to recombine than single-chain variable fragments (scFvs) used in most CARs, but fewer sdAb-CARs have been reported. Thus, we sought to identify a therapeutically active sdAb-CAR targeting human CD22. Immunization of an adult Llama glama with CD22 protein, sdAb-cDNA library construction, and phage panning yielded >20 sdAbs with diverse epitope and binding properties...
March 21, 2024: Mol Ther Oncol
https://read.qxmd.com/read/38593899/generation-and-characterization-of-a-nanobody-against-the-avian-influenza-virus-h7-subtype
#12
JOURNAL ARTICLE
Xiuqin Huang, Weiye Li, Xuewei Cao, Qi Zhang, Yizhen Lin, Siqi Xu, Xinying Dong, Peiqi Liu, Yutong Liu, Ge He, Kaijian Luo, Saixiang Feng
Avian influenza virus (AIV) H7N9 diseases have been recently reported, raising concerns about a potential pandemic. Thus, there is an urgent need for effective therapeutics for AIV H7N9 infections. Herein, camelid immunization and yeast two-hybrid techniques were used to identify potent neutralizing nanobodies (Nbs) targeting the H7 subtype hemagglutinin. First, we evaluated the binding specificity and hemagglutination inhibition activity of the screened Nbs against the H7 subtype hemagglutinin. Nb-Z77, with high hemagglutination inhibition activity was selected from the screened Nbs to optimize the yeast expression conditions and construct oligomeric forms of Nb-Z77 using various ligation methods...
April 7, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38590528/generation-and-characterization-of-antagonistic-anti-human-cd39-nanobodies
#13
JOURNAL ARTICLE
Stephan Menzel, Yinghui Duan, Julia Hambach, Birte Albrecht, Dorte Wendt-Cousin, Riekje Winzer, Eva Tolosa, Anne Rissiek, Andreas H Guse, Friedrich Haag, Tim Magnus, Friedrich Koch-Nolte, Björn Rissiek
CD39 is the major enzyme controlling the levels of extracellular adenosine triphosphate (ATP) via the stepwise hydrolysis of ATP to adenosine diphosphate (ADP) and adenosine monophosphate (AMP). As extracellular ATP is a strong promoter of inflammation, monoclonal antibodies (mAbs) blocking CD39 are utilized therapeutically in the field of immune-oncology. Though anti-CD39 mAbs are highly specific for their target, they lack deep penetration into the dense tissue of solid tumors, due to their large size. To overcome this limitation, we generated and characterized nanobodies that targeted and blocked human CD39...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38590452/design-of-oscillatory-networks-through-post-translational-control-of-network-components
#14
JOURNAL ARTICLE
Brianna E K Jayanthi, Shridhar Jayanthi, Laura Segatori
Many essential functions in biological systems, including cell cycle progression and circadian rhythm regulation, are governed by the periodic behaviors of specific molecules. These periodic behaviors arise from the precise arrangement of components in biomolecular networks that generate oscillatory output signals. The dynamic properties of individual components of these networks, such as maturation delays and degradation rates, often play a key role in determining the network's oscillatory behavior. In this study, we explored the post-translational modulation of network components as a means to generate genetic circuits with oscillatory behaviors and perturb the oscillation features...
June 2023: Synth Biol Eng
https://read.qxmd.com/read/38588947/nanobodies-against-african-swine-fever-virus-p72-and-cd2v-proteins-as-reagents-for-developing-two-celisas-to-detect-viral-antibodies
#15
JOURNAL ARTICLE
Jiahong Zhu, Qingyuan Liu, Liuya Li, Runyu Zhang, Yueting Chang, Jiakai Zhao, Siyu Liu, Xinyu Zhao, Xu Chen, Yani Sun, Qin Zhao
African swine fever virus (ASFV) poses a significant threat to the global swine industry. Currently, there are no effective vaccines or treatments available to combat ASFV infection in pigs. The primary means of controlling the spread of the disease is through rapid detection and subsequent elimination of infected pig. Recently, a lower virulent ASFV isolate with a deleted EP402R gene (CD2v-deleted) has been reported in China, which further complicates the control of ASFV infection the pig farms. Furthermore, an EP402R-deleted ASFV variant has been developed as a potential live attenuated vaccine candidate strain...
April 6, 2024: Virologica Sinica
https://read.qxmd.com/read/38585985/unlocking-precision-gene-therapy-harnessing-aav-tropism-with-nanobody-swapping-at-capsid-hotspots
#16
Mareike D Hoffmann, Joseph P Gallant, Aaron M LeBeau, Daniel Schmidt
Adeno-associated virus has been remarkably successful in the clinic, but its broad tropism is a practical limitation of precision gene therapy. A promising path to engineer AAV tropism is the addition of binding domains to the AAV capsid that recognize cell surface markers present on a targeted cell type. We have recently identified two previously unexplored capsid regions near the 2-fold valley and 5-fold pore of the AAV capsid that are amenable to insertion of larger protein domains including nanobodies. Here, we demonstrate that these hotspots facilitate AAV tropism switching through simple nanobody replacement without extensive optimization in both VP1 and VP2...
March 27, 2024: bioRxiv
https://read.qxmd.com/read/38585932/engineered-nanobodies-with-programmable-target-antigen-proteolysis-ptap-fusions-regulate-intracellular-alpha-synuclein-in-vitro-and-in-vivo
#17
Diptaman Chatterjee, Lianna Y D'Brant, Benjamin M Hiller, David J Marmion, Ivette M Sandoval, Kelvin C Luk, Fredric P Manfredsson, Anne Messer, Jeffrey H Kordower, David C Butler
Alpha-synuclein (αSyn) aggregation and the formation of Lewy pathology (LP) is a foundational pathophysiological phenomenon in synucleinopathies. Delivering therapeutic single-chain and single-domain antibodies that bind pathogenic targets can disrupt intracellular aggregation. The fusion of antibody fragments to a negatively-charged proteasomal targeting motif (PEST) creates bifunctional constructs that enhance both solubility and turnover. With sequence-specific point mutations of PEST sequences that modulate proteasomal degradation efficiency, we report the creation of Programmable Target Antigen Proteolysis (PTAP) technology that can provide graded control over the levels of target antigens...
March 28, 2024: Research Square
https://read.qxmd.com/read/38582966/fast-accurate-ranking-of-engineered-proteins-by-target-binding-propensity-using-structure-modeling
#18
JOURNAL ARTICLE
Xiaozhe Ding, Xinhong Chen, Erin E Sullivan, Timothy F Shay, Viviana Gradinaru
Deep learning-based methods for protein structure prediction have achieved unprecedented accuracy. Yet, their utility in the engineering of protein-based binders remains constrained due to a gap between the ability to predict the structures of candidate proteins and the ability to assess which of those proteins are more probable to bind to a target. To bridge this gap, we introduce Automated Pairwise Peptide-Receptor AnalysIs for Screening Engineered proteins (APPRAISE), a method for predicting the target binding propensity of engineered proteins...
April 5, 2024: Molecular Therapy
https://read.qxmd.com/read/38581990/the-nanobody-targeting-pd-l1-and-cxcr4-counteracts-pancreatic-stellate-cell-mediated-tumour-progression-by-disrupting-tumour-microenvironment
#19
JOURNAL ARTICLE
Yaxian Li, Yuejiang Zheng, Shuyi Xu, Hai Hu, Liyun Peng, Jianwei Zhu, Mingyuan Wu
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal malignancy worldwide owing to its complex tumour microenvironment and dense physical barriers. Stromal-derived factor-1 (SDF-1), which is abundantly secreted by tumour stromal cells, plays a pivotal role in promoting PDAC growth and metastasis. In this study, we investigated the impact and molecular mechanisms of the anti-PD-L1&CXCR4 bispecific nanobody on the TME and their consequent interference with PDAC progression. We found that blocking the SDF-1/CXCR4 signalling pathway delayed the epithelial-mesenchymal transition in pancreatic cancer cells...
April 5, 2024: International Immunopharmacology
https://read.qxmd.com/read/38581977/corrigendum-to-a-specific-nanobody-based-affinity-chromatography-resin-as-a-platform-for-small-ubiquitin-related-modifier-fusion-protein-purification-journal-of-chromatography-a-1713-2024-464508
#20
Zongqing Huang, Haoju Hua, Xiuzhen Du, Zipeng Zhen, Wei Zhao, Jun Feng, Ji-An Li
No abstract text is available yet for this article.
April 5, 2024: Journal of Chromatography. A
keyword
keyword
58440
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.